• Dennis Chun-Yu Ho, Szu-Han Chen, Chih-Yuan Fang, Chang-Wei Hsieh, Pei-Ling Hsieh, Yi-Wen Liao, Cheng-Chia Yu, and Lo-Lin Tsai.
• School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan; Division of Oral and Maxillofacial Surgery, Department of Dentistry, Wan Fang Hospital, Taipei, Taiwan.
• J Formos Med Assoc. 2022 May 1; 121 (5): 930-935.

Background/PurposeBetel nut chewing is the major risk factor of oral submucous fibrosis (OSF). Various studies have sought to discover alternative strategies to alleviate oral fibrogenesis. In the present study, we aimed to evaluate the anti-fibrosis effect of paeonol, a phenolic component derived from Paeonia Suffruticosa.MethodsThe cytotoxicity of paeonol was tested using normal and fibrotic buccal mucosal fibroblasts (fBMFs) derived from OSF tissues. Collagen gel contraction, Transwell migration, invasion, and wound healing capacities were examined. Besides, the activation of TGF-β/Smad2 signaling and expression levels of type I collagen, α-SMA, and long non-coding RNA HOTAIR were measured as well.ResultsPaeonol exerted a higher cytotoxic effect on fBMFs compared to normal BMFs. The arecoline-induced myofibroblast activities, including collagen gel contractility, cell motility, and wound healing ability were all suppressed by paeonol treatment. In addition, the activation of the TGF-β/Smad2 pathway was inhibited along with a lower expression of α-SMA and type I collagen in paeonol-treated cells. Also, the administration of paeonol decreased the mRNA expression of HOTAIR in fBMFs.ConclusionOur results indicate that paeonol may be a promising compound to attenuate the progression of oral fibrogenesis in OSF patients.Copyright © 2021. Published by Elsevier B.V.

19 keywords...

hide…